Pharmaceutical & API manufacturing sites in France

192 drug establishments in France are registered with the US FDA; 64 (33%) list API manufacture among their operations. 141 registrant companies are identified, 9 of them with more than one API site here; sites whose registrant is not resolved to a company profile are not counted. 103 published sites are matched to an EU or UK GMP certificate inspected within the last three years.

Counts are physical site addresses in the FDA's current establishment register (US-facing sites only), not headquarters and not production volume. Methodology

FDA-registered sites
192
Registered for API manufacture
64
Identified registrants
141
Current EU/UK GMP match
103

Registered operations

Analytical testing125
Drug manufacture93
API manufacture64
Packaging58
Labelling55
Repackaging11
Sterilisation10
Relabelling8
Particle size reduction2
Medicated animal feed1

A site can register several operations, so these do not add up to the site total.

Companies headquartered in France

API manufacturing sites (64)

Other sites with EU/UK GMP documents (83)

All 147 published sites in France, A–Z

Only sites registered with the US FDA appear, so manufacturing that serves only other markets is missing and these figures understate national capacity. A GMP match requires the certificate address to name the site's street and its city or postcode; an unmatched site is not an uncertified site.